Copyright Reports & Markets. All rights reserved.

Global Biological Indicators Market 2025 by Company, Regions, Type and Application, Forecast to 2031

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Biological Indicators by Type
    • 1.3.1 Overview: Global Biological Indicators Market Size by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Global Biological Indicators Consumption Value Market Share by Type in 2024
    • 1.3.3 Self-Contained Biological Indicator
    • 1.3.4 Biological Indicator Strip
  • 1.4 Global Biological Indicators Market by Application
    • 1.4.1 Overview: Global Biological Indicators Market Size by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Hospital
    • 1.4.3 Pharma Companies
    • 1.4.4 Others
  • 1.5 Global Biological Indicators Market Size & Forecast
  • 1.6 Global Biological Indicators Market Size and Forecast by Region
    • 1.6.1 Global Biological Indicators Market Size by Region: 2020 VS 2024 VS 2031
    • 1.6.2 Global Biological Indicators Market Size by Region, (2020-2031)
    • 1.6.3 North America Biological Indicators Market Size and Prospect (2020-2031)
    • 1.6.4 Europe Biological Indicators Market Size and Prospect (2020-2031)
    • 1.6.5 Asia-Pacific Biological Indicators Market Size and Prospect (2020-2031)
    • 1.6.6 South America Biological Indicators Market Size and Prospect (2020-2031)
    • 1.6.7 Middle East & Africa Biological Indicators Market Size and Prospect (2020-2031)

2 Company Profiles

  • 2.1 3M
    • 2.1.1 3M Details
    • 2.1.2 3M Major Business
    • 2.1.3 3M Biological Indicators Product and Solutions
    • 2.1.4 3M Biological Indicators Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 3M Recent Developments and Future Plans
  • 2.2 Getinge Group
    • 2.2.1 Getinge Group Details
    • 2.2.2 Getinge Group Major Business
    • 2.2.3 Getinge Group Biological Indicators Product and Solutions
    • 2.2.4 Getinge Group Biological Indicators Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Getinge Group Recent Developments and Future Plans
  • 2.3 Cantel Medical
    • 2.3.1 Cantel Medical Details
    • 2.3.2 Cantel Medical Major Business
    • 2.3.3 Cantel Medical Biological Indicators Product and Solutions
    • 2.3.4 Cantel Medical Biological Indicators Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Cantel Medical Recent Developments and Future Plans
  • 2.4 Mesa Laboratories
    • 2.4.1 Mesa Laboratories Details
    • 2.4.2 Mesa Laboratories Major Business
    • 2.4.3 Mesa Laboratories Biological Indicators Product and Solutions
    • 2.4.4 Mesa Laboratories Biological Indicators Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Mesa Laboratories Recent Developments and Future Plans
  • 2.5 Steris
    • 2.5.1 Steris Details
    • 2.5.2 Steris Major Business
    • 2.5.3 Steris Biological Indicators Product and Solutions
    • 2.5.4 Steris Biological Indicators Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Steris Recent Developments and Future Plans
  • 2.6 Fuze Medical
    • 2.6.1 Fuze Medical Details
    • 2.6.2 Fuze Medical Major Business
    • 2.6.3 Fuze Medical Biological Indicators Product and Solutions
    • 2.6.4 Fuze Medical Biological Indicators Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Fuze Medical Recent Developments and Future Plans
  • 2.7 Matachana
    • 2.7.1 Matachana Details
    • 2.7.2 Matachana Major Business
    • 2.7.3 Matachana Biological Indicators Product and Solutions
    • 2.7.4 Matachana Biological Indicators Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 Matachana Recent Developments and Future Plans
  • 2.8 Hu-Friedy
    • 2.8.1 Hu-Friedy Details
    • 2.8.2 Hu-Friedy Major Business
    • 2.8.3 Hu-Friedy Biological Indicators Product and Solutions
    • 2.8.4 Hu-Friedy Biological Indicators Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 Hu-Friedy Recent Developments and Future Plans
  • 2.9 Advanced Sterilization
    • 2.9.1 Advanced Sterilization Details
    • 2.9.2 Advanced Sterilization Major Business
    • 2.9.3 Advanced Sterilization Biological Indicators Product and Solutions
    • 2.9.4 Advanced Sterilization Biological Indicators Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 Advanced Sterilization Recent Developments and Future Plans
  • 2.10 Bag Health Care
    • 2.10.1 Bag Health Care Details
    • 2.10.2 Bag Health Care Major Business
    • 2.10.3 Bag Health Care Biological Indicators Product and Solutions
    • 2.10.4 Bag Health Care Biological Indicators Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 Bag Health Care Recent Developments and Future Plans
  • 2.11 Terragene
    • 2.11.1 Terragene Details
    • 2.11.2 Terragene Major Business
    • 2.11.3 Terragene Biological Indicators Product and Solutions
    • 2.11.4 Terragene Biological Indicators Revenue, Gross Margin and Market Share (2020-2025)
    • 2.11.5 Terragene Recent Developments and Future Plans
  • 2.12 Andersen
    • 2.12.1 Andersen Details
    • 2.12.2 Andersen Major Business
    • 2.12.3 Andersen Biological Indicators Product and Solutions
    • 2.12.4 Andersen Biological Indicators Revenue, Gross Margin and Market Share (2020-2025)
    • 2.12.5 Andersen Recent Developments and Future Plans
  • 2.13 GKE
    • 2.13.1 GKE Details
    • 2.13.2 GKE Major Business
    • 2.13.3 GKE Biological Indicators Product and Solutions
    • 2.13.4 GKE Biological Indicators Revenue, Gross Margin and Market Share (2020-2025)
    • 2.13.5 GKE Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Biological Indicators Revenue and Share by Players (2020-2025)
  • 3.2 Market Share Analysis (2024)
    • 3.2.1 Market Share of Biological Indicators by Company Revenue
    • 3.2.2 Top 3 Biological Indicators Players Market Share in 2024
    • 3.2.3 Top 6 Biological Indicators Players Market Share in 2024
  • 3.3 Biological Indicators Market: Overall Company Footprint Analysis
    • 3.3.1 Biological Indicators Market: Region Footprint
    • 3.3.2 Biological Indicators Market: Company Product Type Footprint
    • 3.3.3 Biological Indicators Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Biological Indicators Consumption Value and Market Share by Type (2020-2025)
  • 4.2 Global Biological Indicators Market Forecast by Type (2026-2031)

5 Market Size Segment by Application

  • 5.1 Global Biological Indicators Consumption Value Market Share by Application (2020-2025)
  • 5.2 Global Biological Indicators Market Forecast by Application (2026-2031)

6 North America

  • 6.1 North America Biological Indicators Consumption Value by Type (2020-2031)
  • 6.2 North America Biological Indicators Market Size by Application (2020-2031)
  • 6.3 North America Biological Indicators Market Size by Country
    • 6.3.1 North America Biological Indicators Consumption Value by Country (2020-2031)
    • 6.3.2 United States Biological Indicators Market Size and Forecast (2020-2031)
    • 6.3.3 Canada Biological Indicators Market Size and Forecast (2020-2031)
    • 6.3.4 Mexico Biological Indicators Market Size and Forecast (2020-2031)

7 Europe

  • 7.1 Europe Biological Indicators Consumption Value by Type (2020-2031)
  • 7.2 Europe Biological Indicators Consumption Value by Application (2020-2031)
  • 7.3 Europe Biological Indicators Market Size by Country
    • 7.3.1 Europe Biological Indicators Consumption Value by Country (2020-2031)
    • 7.3.2 Germany Biological Indicators Market Size and Forecast (2020-2031)
    • 7.3.3 France Biological Indicators Market Size and Forecast (2020-2031)
    • 7.3.4 United Kingdom Biological Indicators Market Size and Forecast (2020-2031)
    • 7.3.5 Russia Biological Indicators Market Size and Forecast (2020-2031)
    • 7.3.6 Italy Biological Indicators Market Size and Forecast (2020-2031)

8 Asia-Pacific

  • 8.1 Asia-Pacific Biological Indicators Consumption Value by Type (2020-2031)
  • 8.2 Asia-Pacific Biological Indicators Consumption Value by Application (2020-2031)
  • 8.3 Asia-Pacific Biological Indicators Market Size by Region
    • 8.3.1 Asia-Pacific Biological Indicators Consumption Value by Region (2020-2031)
    • 8.3.2 China Biological Indicators Market Size and Forecast (2020-2031)
    • 8.3.3 Japan Biological Indicators Market Size and Forecast (2020-2031)
    • 8.3.4 South Korea Biological Indicators Market Size and Forecast (2020-2031)
    • 8.3.5 India Biological Indicators Market Size and Forecast (2020-2031)
    • 8.3.6 Southeast Asia Biological Indicators Market Size and Forecast (2020-2031)
    • 8.3.7 Australia Biological Indicators Market Size and Forecast (2020-2031)

9 South America

  • 9.1 South America Biological Indicators Consumption Value by Type (2020-2031)
  • 9.2 South America Biological Indicators Consumption Value by Application (2020-2031)
  • 9.3 South America Biological Indicators Market Size by Country
    • 9.3.1 South America Biological Indicators Consumption Value by Country (2020-2031)
    • 9.3.2 Brazil Biological Indicators Market Size and Forecast (2020-2031)
    • 9.3.3 Argentina Biological Indicators Market Size and Forecast (2020-2031)

10 Middle East & Africa

  • 10.1 Middle East & Africa Biological Indicators Consumption Value by Type (2020-2031)
  • 10.2 Middle East & Africa Biological Indicators Consumption Value by Application (2020-2031)
  • 10.3 Middle East & Africa Biological Indicators Market Size by Country
    • 10.3.1 Middle East & Africa Biological Indicators Consumption Value by Country (2020-2031)
    • 10.3.2 Turkey Biological Indicators Market Size and Forecast (2020-2031)
    • 10.3.3 Saudi Arabia Biological Indicators Market Size and Forecast (2020-2031)
    • 10.3.4 UAE Biological Indicators Market Size and Forecast (2020-2031)

11 Market Dynamics

  • 11.1 Biological Indicators Market Drivers
  • 11.2 Biological Indicators Market Restraints
  • 11.3 Biological Indicators Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Biological Indicators Industry Chain
  • 12.2 Biological Indicators Upstream Analysis
  • 12.3 Biological Indicators Midstream Analysis
  • 12.4 Biological Indicators Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Biological Indicators market size was valued at US$ 423 million in 2024 and is forecast to a readjusted size of USD 623 million by 2031 with a CAGR of 5.8% during review period.
    Biological indicators (BIs), as defined by ANSI/AAMI and ISO, are test systems containing viable microorganisms providing a defined resistance to a specific sterilization process. A biological indicator provides information on whether necessary conditions were met to kill a specified number of microorganisms for a given sterilization process, providing a level of confidence in the process.
    Global Biological Indicators main players are 3M, Getinge Group, Cantel Medical, Mesa Laboratories, Steris, etc. Global top five manufacturers hold a share over 65%. North America is the largest market, with a share nearly 55%.
    This report is a detailed and comprehensive analysis for global Biological Indicators market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Biological Indicators market size and forecasts, in consumption value ($ Million), 2020-2031
    Global Biological Indicators market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
    Global Biological Indicators market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
    Global Biological Indicators market shares of main players, in revenue ($ Million), 2020-2025
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Biological Indicators
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Biological Indicators market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include 3M, Getinge Group, Cantel Medical, Mesa Laboratories, Steris, Fuze Medical, Matachana, Hu-Friedy, Advanced Sterilization, Bag Health Care, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    Biological Indicators market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Self-Contained Biological Indicator
    Biological Indicator Strip
    Market segment by Application
    Hospital
    Pharma Companies
    Others
    Market segment by players, this report covers
    3M
    Getinge Group
    Cantel Medical
    Mesa Laboratories
    Steris
    Fuze Medical
    Matachana
    Hu-Friedy
    Advanced Sterilization
    Bag Health Care
    Terragene
    Andersen
    GKE
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Biological Indicators product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Biological Indicators, with revenue, gross margin, and global market share of Biological Indicators from 2020 to 2025.
    Chapter 3, the Biological Indicators competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Biological Indicators market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Biological Indicators.
    Chapter 13, to describe Biological Indicators research findings and conclusion.

    Buy now